TScan Therapeutics (TCRX) Competitors $1.51 +0.04 (+2.72%) As of 03:55 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TCRX vs. MBX, AQST, CYRX, IVA, OCGN, PRTA, HRTX, AURA, TKNO, and RCKTShould you be buying TScan Therapeutics stock or one of its competitors? The main competitors of TScan Therapeutics include MBX Biosciences (MBX), Aquestive Therapeutics (AQST), CryoPort (CYRX), Inventiva (IVA), Ocugen (OCGN), Prothena (PRTA), Heron Therapeutics (HRTX), Aura Biosciences (AURA), Alpha Teknova (TKNO), and Rocket Pharmaceuticals (RCKT). These companies are all part of the "pharmaceutical products" industry. TScan Therapeutics vs. Its Competitors MBX Biosciences Aquestive Therapeutics CryoPort Inventiva Ocugen Prothena Heron Therapeutics Aura Biosciences Alpha Teknova Rocket Pharmaceuticals MBX Biosciences (NYSE:MBX) and TScan Therapeutics (NASDAQ:TCRX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, earnings, valuation, media sentiment, risk, profitability, analyst recommendations and dividends. Do insiders & institutionals hold more shares of MBX or TCRX? 82.8% of TScan Therapeutics shares are owned by institutional investors. 52.2% of MBX Biosciences shares are owned by company insiders. Comparatively, 4.4% of TScan Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is MBX or TCRX more profitable? MBX Biosciences has a net margin of 0.00% compared to TScan Therapeutics' net margin of -2,974.08%. MBX Biosciences' return on equity of 0.00% beat TScan Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets MBX BiosciencesN/A N/A N/A TScan Therapeutics -2,974.08%-55.76%-36.56% Which has stronger valuation & earnings, MBX or TCRX? MBX Biosciences has higher earnings, but lower revenue than TScan Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMBX BiosciencesN/AN/AN/AN/AN/ATScan Therapeutics$2.82M30.30-$127.50M-$1.09-1.39 Does the media prefer MBX or TCRX? In the previous week, MBX Biosciences had 1 more articles in the media than TScan Therapeutics. MarketBeat recorded 1 mentions for MBX Biosciences and 0 mentions for TScan Therapeutics. MBX Biosciences' average media sentiment score of 0.00 equaled TScan Therapeutics'average media sentiment score. Company Overall Sentiment MBX Biosciences Neutral TScan Therapeutics Neutral Do analysts rate MBX or TCRX? MBX Biosciences presently has a consensus target price of $37.50, suggesting a potential upside of 200.60%. TScan Therapeutics has a consensus target price of $7.80, suggesting a potential upside of 416.56%. Given TScan Therapeutics' higher possible upside, analysts clearly believe TScan Therapeutics is more favorable than MBX Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score MBX Biosciences 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00TScan Therapeutics 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryMBX Biosciences beats TScan Therapeutics on 6 of the 9 factors compared between the two stocks. Get TScan Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TCRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TCRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TCRX vs. The Competition Export to ExcelMetricTScan TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$85.45M$2.89B$5.49B$9.01BDividend YieldN/A2.64%5.39%4.11%P/E Ratio-1.3921.5427.4320.07Price / Sales30.30283.12397.97109.45Price / CashN/A41.4736.1356.90Price / Book0.357.518.015.67Net Income-$127.50M-$55.05M$3.16B$248.47M7 Day Performance2.03%3.21%2.19%2.90%1 Month Performance-13.71%5.97%4.49%5.75%1 Year Performance-74.23%5.88%35.68%21.39% TScan Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TCRXTScan Therapeutics2.128 of 5 stars$1.51+2.7%$7.80+416.6%-74.3%$85.45M$2.82M-1.39100MBXMBX Biosciences2.3803 of 5 stars$9.73-0.1%$37.50+285.4%N/A$325.22MN/A0.0036AQSTAquestive Therapeutics1.5976 of 5 stars$3.29+1.2%$10.14+208.3%+52.1%$322.82M$57.56M-5.58160News CoverageCYRXCryoPort2.0896 of 5 stars$6.56+3.0%$11.00+67.7%+20.4%$319.37M$228.38M-2.801,186IVAInventiva2.7768 of 5 stars$3.34+1.5%$10.40+211.5%+4.6%$314.73M$9.95M0.00100OCGNOcugen0.9993 of 5 stars$0.98-7.4%$6.00+511.6%-42.5%$309.55M$4.05M-5.1680High Trading VolumePRTAProthena3.2268 of 5 stars$6.06+5.9%$31.50+419.8%-69.0%$307.89M$135.16M-2.91130High Trading VolumeHRTXHeron Therapeutics4.0531 of 5 stars$2.11+5.5%$5.00+137.0%-21.5%$305.13M$144.29M-35.17300AURAAura Biosciences1.714 of 5 stars$6.15+1.8%$22.00+257.7%-9.7%$303.62MN/A-3.2450TKNOAlpha Teknova3.0464 of 5 stars$5.28-5.0%$8.50+61.0%+313.8%$297.13M$37.74M-11.00240News CoverageRCKTRocket Pharmaceuticals4.8905 of 5 stars$2.63-2.6%$18.60+607.2%-85.4%$288.32MN/A-1.00240Trending News Related Companies and Tools Related Companies MBX Biosciences Competitors Aquestive Therapeutics Competitors CryoPort Competitors Inventiva Competitors Ocugen Competitors Prothena Competitors Heron Therapeutics Competitors Aura Biosciences Competitors Alpha Teknova Competitors Rocket Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TCRX) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersHere's the last trade you should make before heading out for the weekend tomorrow.Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.Timothy Sykes | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredHow to Collect Up To $5,917/mo From Trump’s Made In USA BoomHow to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First poli...Investors Alley | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TScan Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TScan Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
